Mark E. Olah

4.7k total citations · 1 hit paper
59 papers, 4.0k citations indexed

About

Mark E. Olah is a scholar working on Molecular Biology, Physiology and Organic Chemistry. According to data from OpenAlex, Mark E. Olah has authored 59 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 33 papers in Physiology and 12 papers in Organic Chemistry. Recurrent topics in Mark E. Olah's work include Adenosine and Purinergic Signaling (33 papers), Pharmacological Receptor Mechanisms and Effects (18 papers) and Receptor Mechanisms and Signaling (17 papers). Mark E. Olah is often cited by papers focused on Adenosine and Purinergic Signaling (33 papers), Pharmacological Receptor Mechanisms and Effects (18 papers) and Receptor Mechanisms and Signaling (17 papers). Mark E. Olah collaborates with scholars based in United States, Hungary and Italy. Mark E. Olah's co-authors include Gary L. Stiles, Kenneth A. Jacobson, Neli Melman, Robert A. Johnson, Olivier Civelli, Qun Zhou, Chuanfu Li, Carola Gallo‐Rodriguez, Xiao-duo Ji and Suhaib M. Siddiqi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The FASEB Journal.

In The Last Decade

Mark E. Olah

56 papers receiving 4.0k citations

Hit Papers

Molecular cloning and cha... 1992 2026 2003 2014 1992 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mark E. Olah 2.8k 2.3k 1.1k 670 302 59 4.0k
Marlene A. Jacobson 1.9k 0.7× 2.4k 1.0× 1.8k 1.7× 382 0.6× 444 1.5× 75 4.9k
Fabrizio Vincenzi 2.2k 0.8× 1.8k 0.8× 996 0.9× 644 1.0× 492 1.6× 135 5.0k
Björn Kull 1.8k 0.7× 1.6k 0.7× 946 0.9× 251 0.4× 253 0.8× 32 3.3k
Angela Monopoli 1.5k 0.5× 1.3k 0.6× 797 0.8× 268 0.4× 421 1.4× 93 3.2k
Stefania Ceruti 2.1k 0.8× 1.5k 0.6× 1.1k 1.1× 187 0.3× 553 1.8× 93 4.2k
Gunnar Schulte 1.6k 0.6× 3.7k 1.6× 1.7k 1.6× 161 0.2× 485 1.6× 112 6.1k
Ivar von Kügelgen 3.2k 1.1× 2.5k 1.1× 1.3k 1.3× 256 0.4× 857 2.8× 100 5.3k
Anton D. Michel 863 0.3× 1.3k 0.6× 917 0.9× 261 0.4× 594 2.0× 55 2.6k
Edward Leung 1.1k 0.4× 1.0k 0.4× 379 0.4× 364 0.5× 156 0.5× 52 2.2k
Dilip K. Tosh 1.3k 0.5× 1.4k 0.6× 538 0.5× 452 0.7× 297 1.0× 96 2.5k

Countries citing papers authored by Mark E. Olah

Since Specialization
Citations

This map shows the geographic impact of Mark E. Olah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Olah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Olah more than expected).

Fields of papers citing papers by Mark E. Olah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark E. Olah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Olah. The network helps show where Mark E. Olah may publish in the future.

Co-authorship network of co-authors of Mark E. Olah

This figure shows the co-authorship network connecting the top 25 collaborators of Mark E. Olah. A scholar is included among the top collaborators of Mark E. Olah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark E. Olah. Mark E. Olah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olah, Mark E., Loc Trinh, Ying Liu, et al.. (2019). Involvement of CREB-regulated transcription coactivators (CRTC) in transcriptional activation of steroidogenic acute regulatory protein (Star) by ACTH. Molecular and Cellular Endocrinology. 499. 110612–110612. 10 indexed citations
2.
Olah, Mark E., et al.. (2014). Trametinib and Dabrafenib: New Agents for Advanced Stage Melanoma. 5(2). 44–47.
3.
Olah, Mark E., et al.. (2012). Impact of Community Pharmacists on Management of Cancer Chemotherapy and the Resulting Side Effects. 3(2). 40–45.
4.
Liu, Ying, et al.. (2012). Transcriptional regulation of episodic glucocorticoid secretion. Molecular and Cellular Endocrinology. 371(1-2). 62–70. 29 indexed citations
5.
Olah, Mark E., et al.. (2011). Role of salsolinol in the regulation of pituitary prolactin and peripheral dopamine release. Reproductive Medicine and Biology. 10(3). 143–151. 4 indexed citations
6.
Fehér, Pálma, Mark E. Olah, Ibolya Bodnár, et al.. (2010). Dephosphorylation/inactivation of tyrosine hydroxylase at the median eminence of the hypothalamus is required for suckling-induced prolactin and adrenocorticotrop hormone responses. Brain Research Bulletin. 82(1-2). 141–145. 16 indexed citations
7.
Olah, Mark E., Pálma Fehér, Ildikó Bácskay, et al.. (2009). Dopamine-Regulated Adrenocorticotropic Hormone Secretion in Lactating Rats: Functional Plasticity of Melanotropes. Neuroendocrinology. 90(4). 391–401. 12 indexed citations
8.
Botos, Erzsébet, Judith Klumperman, Viola Oorschot, et al.. (2008). Caveolin‐1 is transported to multi‐vesicular bodies after albumin‐induced endocytosis of caveolae in HepG2 cells. Journal of Cellular and Molecular Medicine. 12(5a). 1632–1639. 32 indexed citations
9.
HASHIZUME, Tsutomu, Shuichi Suzuki, Etsuko Kasuya, et al.. (2007). Interaction between salsolinol (SAL) and thyrotropin-releasing hormone (TRH) or dopamine (DA) on the secretion of prolactin in ruminants. Domestic Animal Endocrinology. 34(3). 327–332. 20 indexed citations
10.
Kwon, Ohwon, Maureen A. Sartor, Craig R. Tomlinson, et al.. (2006). Effect of simulated microgravity on oxidation-sensitive gene expression in PC12 cells. Advances in Space Research. 38(6). 1168–1176. 5 indexed citations
12.
Olah, Mark E.. (1997). Identification of A2a Adenosine Receptor Domains Involved in Selective Coupling to GS. Journal of Biological Chemistry. 272(1). 337–344. 73 indexed citations
13.
Jacobson, Kenneth A., Kyung Park, Ji-long Jiang, et al.. (1997). Pharmacological characterization of novel A3 adenosine receptor-selective antagonists. Neuropharmacology. 36(9). 1157–1165. 140 indexed citations
14.
Jacobson, Kenneth A., et al.. (1995). A3-adenosine receptors: Design of selective ligands and therapeutic prospects. Drugs of the Future. 20(7). 689–689. 115 indexed citations
15.
Bergen, Anna, Carola Gallo‐Rodriguez, Neli Melman, et al.. (1994). A binding site model and structure-activity relationships for the rat A3 adenosine receptor.. Molecular Pharmacology. 45(6). 1101–1111. 150 indexed citations
16.
Kim, Hea Ok, Xiao‐duo Ji, Neli Melman, et al.. (1994). Structure-Activity Relationships of 1,3-Dialkylxanthine Derivatives at Rat A3 Adenosine Receptors. Journal of Medicinal Chemistry. 37(20). 3373–3382. 45 indexed citations
17.
Jacobson, Kenneth A., Philip J. M. van Galen, Xiao‐duo Ji, et al.. (1993). Molecular characterization of A1 and A2a adenosine receptors. Drug Development Research. 28(3). 226–231. 13 indexed citations
18.
Ramkumar, Vickram, Mark E. Olah, Kenneth A. Jacobson, & Gary L. Stiles. (1991). Distinct Pathways of Desensitization of A1- and A2-Adenosine Receptors in DDT1 MF-2 Cells. Molecular Pharmacology. 40(5). 639–647. 120 indexed citations
19.
20.
Olah, Mark E. & Ralf G. Rahwan. (1987). Age-Related Changes in Responsiveness of the Rat Aorta to Depolarizing and Receptor-Mediated Contractile Stimuli and to Calcium Antagonism1. Pharmacology. 35(3). 163–173. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026